Medicare Enrolled

Dr. Cheryl Verma, M.D.

Family Medicine · Texarkana, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
5002 COWHORN CREEK RD, Texarkana, TX 75503
9036143000
In practice since 2009 (16 years)
NPI: 1588807655 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Verma from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Verma? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Verma

Dr. Cheryl Verma is a family medicine in Texarkana, TX, with 16 years in practice. Based on federal Medicare data, Dr. Verma performed 3,553 Medicare services across 1,771 unique beneficiaries.

Between the years covered by Open Payments, Dr. Verma received a total of $1,996 from 27 pharmaceutical and/or device companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Verma is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 6% volume in TX$ $1,996 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,553
Medicare services
Top 6% in TX for family medicine
1,771
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~222 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)960$18$25
Blood draw (venipuncture)394$8$20
Office visit, established patient (30-39 min)334$78$245
Office visit, established patient (20-29 min)196$58$175
Hemoglobin A1c test (diabetes monitoring)180$9$61
Comprehensive metabolic blood panel178$10$105
Lipid panel (cholesterol and triglycerides)158$13$90
Complete blood count (CBC) with differential132$8$48
Thyroid stimulating hormone (TSH) test99$16$86
Vitamin D level test65$29$250
Basic metabolic blood panel63$8$88
Urinalysis with microscopic exam60$3$28
Urine culture, bacterial identification54$8$42
Flu vaccine administration47$30$35
Flu vaccine, high-dose43$72$75
Magnesium level test42$7$37
Annual wellness visit, follow-up39$117$220
Drug injection, under skin or into muscle37$10$42
Office visit, established patient, complex (40-54 min)35$112$345
Vitamin B-12 level test30$15$70
Folic acid level test29$14$79
Thyroxine (thyroid chemical), total28$7$40
Administration of vaccine24$10$48
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a24$31$110
New patient office visit (45-59 min)21$101$315
Ferritin level test (iron stores)19$13$52
Iron level test19$6$39
Electrocardiogram (EKG), 12-lead19$7$76
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow19$79$200
Transferrin (iron binding protein) level18$12$50
Bacterial culture, aerobic18$8$40
Antibiotic sensitivity test18$8$58
Urine microalbumin test (kidney screening)17$6$58
Creatinine test (kidney function)17$5$22
Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use17$281$325
Pneumonia vaccine administration17$30$45
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and17$38$155
Chest X-ray, 2 views15$16$44
PSA test (prostate cancer screening)15$18$79
Liver function blood test panel14$8$90
New patient office visit (30-44 min)11$65$215
Injection, methylprednisolone sodium succinate, up to 125 mg11$4$16
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,996
Total received (2021-2024)
Avg $499/year across 4 years
Top 27% in TX for family medicine
27
Companies
133
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,996 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$907
2023
$531
2022
$346
2021
$211

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$293
Novartis Pharmaceuticals Corporation
$265
ABBVIE INC.
$250
AbbVie Inc.
$198
PFIZER INC.
$149
Abbott Laboratories
$100
Lilly USA, LLC
$91
Dexcom, Inc.
$89
E.R. Squibb & Sons, L.L.C.
$75
Boehringer Ingelheim Pharmaceuticals, Inc.
$70
GlaxoSmithKline, LLC.
$54
Eisai Inc.
$46
Novo Nordisk Inc
$43
Alnylam Pharmaceuticals Inc.
$41
EVOKE PHARMA, INC.
$31
Arbor Pharmaceuticals, Inc.
$28
Phathom Pharmaceuticals, Inc.
$23
Boston Scientific Corporation
$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$20
Nestle HealthCare Nutrition Inc.
$17
Amarin Pharma Inc.
$15
Evoke Pharma, Inc.
$14
Astellas Pharma US Inc
$14
Esperion Therapeutics, Inc.
$13
Nevro Corp.
$13
Janssen Pharmaceuticals, Inc
$13
Braintree Laboratories, Inc.
$11
Top 3 companies account for 40.5% of total payments
Associated products mentioned in payments ›
CREON · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EVENITY · Edarbi · Edarbyclor · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · GIMOTI · JARDIANCE · LEQVIO · LINZESS · Leqembi · MOTOFEN · NEXLETOL · ONPATTRO · Omnia · Otezla · Ozempic · PREVNAR 20 · QULIPTA · Repatha · SHINGRIX · UBRELVY · VOQUEZNA · VRAYLAR · Vascepa · Veozah · WATCHMAN FLX · Wegovy · XARELTO · XIFAXAN · ZENPEP · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $56 per 100 Medicare services performed
Looking for a family medicine in Texarkana?
Compare family medicines in the Texarkana area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
68
Per 100K population
73.7
County median income
$59,295
Nearest hospital
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Verma is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), and low-engagement industry engagement, with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Verma experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Verma performed 960 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Verma receive payments from pharmaceutical companies?
Yes. Dr. Verma received a total of $1,996 from 27 companies across 133 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Verma's costs compare to other family medicines in Texarkana?
Dr. Verma's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Verma) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →